X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA UNICHEM LAB ALEMBIC PHARMA/
UNICHEM LAB
 
P/E (TTM) x 26.5 22.6 117.6% View Chart
P/BV x 6.1 2.4 254.8% View Chart
Dividend Yield % 0.8 0.8 97.3%  

Financials

 ALEMBIC PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
UNICHEM LAB
Mar-16
ALEMBIC PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs792334 237.0%   
Low Rs443174 254.6%   
Sales per share (Unadj.) Rs167.0146.9 113.7%  
Earnings per share (Unadj.) Rs38.211.9 320.9%  
Cash flow per share (Unadj.) Rs42.016.2 259.4%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.60.8 82.3%  
Book value per share (Unadj.) Rs84.9105.1 80.8%  
Shares outstanding (eoy) m188.5290.84 207.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.71.7 213.8%   
Avg P/E ratio x16.221.4 75.7%  
P/CF ratio (eoy) x14.715.7 93.7%  
Price / Book Value ratio x7.32.4 300.9%  
Dividend payout %10.516.8 62.3%   
Avg Mkt Cap Rs m116,38323,073 504.4%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m4,2142,558 164.7%   
Avg. sales/employee Rs ThNM2,352.5-  
Avg. wages/employee Rs ThNM450.9-  
Avg. net profit/employee Rs ThNM190.4-  
INCOME DATA
Net Sales Rs m31,48713,346 235.9%  
Other income Rs m55192 28.7%   
Total revenues Rs m31,54213,538 233.0%   
Gross profit Rs m10,0601,639 613.8%  
Depreciation Rs m722390 185.2%   
Interest Rs m3729 127.8%   
Profit before tax Rs m9,3561,412 662.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-4 40.5%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m2,160293 738.0%   
Profit after tax Rs m7,1941,080 665.9%  
Gross profit margin %31.912.3 260.1%  
Effective tax rate %23.120.7 111.4%   
Net profit margin %22.88.1 282.2%  
BALANCE SHEET DATA
Current assets Rs m15,0665,979 252.0%   
Current liabilities Rs m7,6742,432 315.6%   
Net working cap to sales %23.526.6 88.3%  
Current ratio x2.02.5 79.8%  
Inventory Days Days6763 106.2%  
Debtors Days Days4160 67.3%  
Net fixed assets Rs m8,2376,403 128.7%   
Share capital Rs m377182 207.5%   
"Free" reserves Rs m15,4169,293 165.9%   
Net worth Rs m16,0059,548 167.6%   
Long term debt Rs m0230 0.0%   
Total assets Rs m24,59412,843 191.5%  
Interest coverage x255.250.0 510.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.31.0 123.2%   
Return on assets %29.48.6 340.4%  
Return on equity %44.911.3 397.3%  
Return on capital %58.714.3 409.3%  
Exports to sales %55.729.2 190.8%   
Imports to sales %10.46.3 164.3%   
Exports (fob) Rs m17,5513,900 450.1%   
Imports (cif) Rs m3,283847 387.7%   
Fx inflow Rs m17,8114,356 408.8%   
Fx outflow Rs m5,3181,162 457.5%   
Net fx Rs m12,4933,194 391.1%   
CASH FLOW
From Operations Rs m9,3041,119 831.4%  
From Investments Rs m-3,105-853 363.9%  
From Financial Activity Rs m-1,959-334 586.2%  
Net Cashflow Rs m4,240-68 -6,207.9%  

Share Holding

Indian Promoters % 74.1 50.1 147.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 15.1 19.2%  
FIIs % 9.1 3.0 303.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 31.7 43.8%  
Shareholders   49,328 20,176 244.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Amid Fed and ECB Minutes, L&T, Power Grid & IOC Among Other Top Stocks to Watch Out Today(Pre-Open)

On Thursday, Indian share markets oscillated between green and red in a broad range throughout the day and ended the session with marginal gains, with Nifty holding 9,900 mark.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS